URA, which is now valued at more than $5bn, is set to integrate Dexcom’s glucose capabilities with the Oura ring.

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

We have worked to find the best capture cards currently on the market, and you can rest assured that we've done our research.

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

"DigiCoach program" is a pilot program by Singapore Health Promotion Board, Health2Sync, and Abbott that aims to help individuals with pre-diabetes or high BMI prevent or delay the onset of diabetes.

The Kilkenny, Ireland facility will focus on the global manufacturing of sensors for Abbott’s CGM diabetes devices.

American Diversified Holdings Corporation (ADHC) Retains Dr. Stephen C. Weber, MD, FACS As Head of Medical Advisory Board ...

Medical device maker Dexcom said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion. Ōura, founded in Finland in 2013, makes a smart ...

Wearing a CGM has made living with diabetes much more manageable for ... The tubed pumps are as small as a beeper or phone ...

Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors ... About 23% of Oura members ...

Tata Electronics and Taiwanese electronics manufacturer Pegatron Corporation have, reportedly, reached an agreement under ...